Live Your Vision’s Theravance Biopharma TBPH Stock Holding History

Live Your Vision’s Portfolio TBPH Stock Details TBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-164	Closed	-$5.36K	–	308
2017 Q2	$6K	Hold	164	–	–	﹤0.01%	220
2017 Q1	$6K	Hold	164	–	–	﹤0.01%	226
2016 Q4	$5K	Hold	164	–	–	﹤0.01%	228
2016 Q3	$6K	Buy	+164	New	+$4.57K	﹤0.01%	210

Other funds holding TBPH

WIM

Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Live Your Vision's TBPH Position: Q3 2017 in Review

Live Your Vision sold out of Theravance Biopharma (TBPH) in Q3 2017, closing a stake of 164 shares — an estimated $5.36K sold.

Live Your Vision first reported a position in TBPH in Q3 2016 and held it in 4 quarters. The position peaked at $6K in Q2 2017. 84 funds tracked by Wall St. Rank hold TBPH as of Q3 2017.

Live Your Vision reported no remaining Theravance Biopharma position as of Q3 2017 after selling out during the quarter.
Live Your Vision sold 164 Theravance Biopharma shares in Q3 2017, an estimated $5.36K.
Live Your Vision first reported a position in Theravance Biopharma in Q3 2016 and held it in 4 quarters.
Live Your Vision's Theravance Biopharma position peaked at $6K in Q2 2017.
84 funds tracked by Wall St. Rank held Theravance Biopharma as of Q3 2017.

Based on Live Your Vision's 13F filing for Q3 2017, filed 13 Nov 2017.